Hyperphosphatemia

Ardelyx Inc. is leading a lawsuit against CMS about plans by the agency to include oral-only phosphate-lowering therapies into the End-Stage Renal Disease Prospective Payment System by January 2025.

Approximately 77,000 people in the U.S. have hypoparathyroidism due to absent or subphysiological levels of parathyroid hormone.

Healio has compiled a list of the most-read nephrology cover stories in 2023.

PHILADELPHIA — Tenapanor in combination with sevelamer may control serum phosphate levels in patients with hyperphosphatemia on dialysis, according to data from ASN Kidney Week.

  Healio spoke with Daniel Coyne, MD, professor of medicine in the nephrology division at Washington University School of Medicine, about the challenges of managing hyperphosphatemia, new treatments and therapies, unmet needs in hyperphosphatemia management and more.

  Healio spoke with Daniel Coyne, MD, professor of medicine in the nephrology division at Washington University School of Medicine, about the challenges of managing hyperphosphatemia, new treatments and therapies, unmet needs in hyperphosphatemia management and more.

  Healio spoke with Daniel Coyne, MD, professor of medicine in the nephrology division at Washington University School of Medicine, about the challenges of managing hyperphosphatemia, new treatments and therapies, unmet needs in hyperphosphatemia management and more.

  Healio spoke with Daniel Coyne, MD, professor of medicine in the nephrology division at Washington University School of Medicine, about the challenges of managing hyperphosphatemia, new treatments and therapies, unmet needs in hyperphosphatemia management and more.

  Healio spoke with Kevin Martin, MD, professor of medicine and director of the division of nephrology at Saint Louis University School of Medicine, about the challenges of managing hyperphosphatemia, prevention measures to recommend to patients at high risk for developing the condition, unmet needs in hyperphosphatemia management and more.

  Healio spoke with Kevin Martin, MD, professor of medicine and director of the division of nephrology at Saint Louis University School of Medicine, about the challenges of managing hyperphosphatemia, prevention measures to recommend to patients at high risk for developing the condition, unmet needs in hyperphosphatemia management and more.